Iwahashi Hiromi | Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A Common P2 Promoter Polymorphism of the Hepatocyte Nuclear Factor-4α Gene Is Associated with Insulin Secretion in Non-Obese Japanese with Type 2 Diabetes
Analysis of Expression Profiles of Islet-associated Transcription and Growth Factors During β-Cell Neogenesis from Duct Cells in Partially Duct-ligated Mice
Successful Use of ^In-Pentetrotide Scintigraphy for Localizing Ectopic Adrenocorticotropin-Producing Bronchial Carcinoid Tumor in a Patient with Cushing's Syndrome
β Cell Neogenesis from Ducts and Phenotypic Conversion of Residual Islet Cells in the Adult Pancreas of Glucose Intolerant Mice Induced by Selective Alloxan Perfusion
PGC-1α Gly482Ser Polymorphism Is Associated with the Plasma Adiponectin Level in Type 2 Diabetic Men
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism : Is there a link?
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
Association of low serum adiponectin levels with erosive esophagitis in men : an analysis of 2405 subjects undergoing physical check-ups
Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin

もっと見る

スポンサーリンク